J
Jane M. Andrews
Researcher at Royal Adelaide Hospital
Publications - 329
Citations - 14638
Jane M. Andrews is an academic researcher from Royal Adelaide Hospital. The author has contributed to research in topics: Inflammatory bowel disease & Medicine. The author has an hindex of 48, co-authored 298 publications receiving 12270 citations. Previous affiliations of Jane M. Andrews include St. Vincent's Health System & Health Science University.
Papers
More filters
Journal ArticleDOI
Experience With and Attitudes Toward Psychotherapy and Antidepressants Among Patients With Inflammatory Bowel Disease and Functional Gastrointestinal Disorders: An Online Patient Survey to Inform System Design.
TL;DR: Given the high desire for and positive experiences of psychological care for these 2 common GI conditions, access to formal psychological support services within GI clinics would appear to be the most efficient model.
Journal ArticleDOI
Combination of corticosteroids and 5-aminosalicylates or corticosteroids alone for patients with moderate-severe active ulcerative colitis: A global survey of physicians' practice.
Shomron Ben-Horin,Jane M. Andrews,Konstantinos H. Katsanos,Florian Rieder,Flavio Steinwurz,Konstantinos Karmiris,Jae Hee Cheon,Gordon W. Moran,Monica Cesarini,Christian D. Stone,Doron Schwartz,Marijana Nedeljkovic Protic,Xavier Roblin,Giulia Roda,Min Hu Chen,Ofir Har-Noy,Charles N. Bernstein +16 more
TL;DR: Despite the absence of data supporting its benefit, most gastroenterologists endorse combination of 5ASA + CS for patients with active moderate-to-severe UC, and on multi-variable analysis, less years of practice and perception of a plausible additive mechanistic effect of 5 ASA +CS were positively associated with the decision to continue5ASA with CS.
Journal ArticleDOI
Longitudinal analysis indicates symptom severity influences immune profile in irritable bowel syndrome
TL;DR: A longitudinal study of patients with IBS comparing immune function within patients when symptom free and when they experience symptom flare is performed, finding that psychological status inversely correlates with immune profile in the development of post infected IBS.
Journal ArticleDOI
OP24 Clinical efficacy and safety of guselkumab maintenance therapy in patients with moderately to severely active Crohn’s Disease: Week 48 analyses from the phase 2 GALAXI 1 study
Silvio Danese,Remo Panaccione,D. Rubin,B.E. Sands,Walter Reinisch,Geert R. D'Haens,Julián Panés,S Gonzalez,Kathleen M. Weisel,Anwesa Sahoo,Mary Ellen Frustaci,Z. Yang,W J Sandborn,Anita Afzali,Tadanori Hisamatsu,Jane M. Andrews,BG Feagan +16 more
TL;DR: GUS induction followed by SC maintenance achieved high rates of clinical efficacy at Wk48 and key safety event rates were similar among GUS dose groups (Table 3); no opportunistic infections, cases of tuberculosis, or deaths were reported in any group.
Journal ArticleDOI
The Adequacy of Habitual Dietary Fiber Intake in Individuals With Inflammatory Bowel Disease: A Systematic Review.
TL;DR: The authors identified studies measuring fiber intakes of individuals with inflammatory bowel disease and compared the adequacy of fiber intakes with that of control groups or respective national dietary guidelines, and examined factors associated with fiber consumption.